Ripped From The Headlines A(n Eventful) Year In Review 2020

In this installment of Medmarc’s webinar series, Kate Klaus, an attorney and FDA specialist in our Risk Management department, guides a discussion of the top life sciences news stories of the past year and their potential implications for products liability. Topics include:
•The dramatic impact of COVID-19 and the life sciences industry’s response to the pandemic;
•Changes at FDA driven by the COVID-19 pandemic and their impact on the industry; and
•How potential changes in leadership at the Department of Health and Human Services and FDA may shape the coming year.